In vitro diagnosis of immediate IgE-mediated drug hypersensitivity: Warnings and (Unmet) Needs

Immunology and Allergy Clinics of North America

Volumn 34, Issue 3, 2014, Pages 681-689

  Uyttebroek, Astrid P ^a   Sabato, Vito ^a   Bridts, Chris H ^a   Ebo, Didier G ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Basophil activation; Drug provocation; Flow cytometry; IgE; Immediate drug allergy

Indexed keywords

BETA LACTAM ANTIBIOTIC; IMMUNOGLOBULIN E; ROCURONIUM; SUXAMETHONIUM;

ANTIBODY SPECIFICITY; BASOPHIL; BASOPHIL ACTIVATION TEST; CELL ACTIVATION; CLINICAL PRACTICE; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; HUMAN; IMMEDIATE IGE MEDIATED DRUG HYPERSENSITIVITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE FUNCTION TEST; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; MAST CELL; PENICILLIN ALLERGY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROVOCATION TEST; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SKIN TEST; BLOOD; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGY; PROCEDURES;

DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOASSAY; IMMUNOGLOBULIN E;

EID: 84904120626     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2014.04.007     Document Type: Review

References (49)

1. Demoly P., Romano A., Botelho C., et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 2010, 65:327-332.
2. Ebo D.G., Leysen J., Mayorga C., et al. The invitro diagnosis of drug allergy: status and perspectives. Allergy 2011, 66:1275-1286.
3. Torres M.J., Blanca M., Fernandez J., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003, 58:961-972.
4. Fontaine C., Mayorga C., Bousquet P.J., et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 2007, 62:47-52.
5. Silva R., Cruz L., Botelho C., et al. Immediate hypersensitivity to penicillins with negative skin tests-the value of specific IgE. Eur Ann Allergy Clin Immunol 2009, 41:117-119.
6. Qiao H.L., Li Z., Yang J., et al. Hypersensitivity reactions to penicillins: studies in a group of patients with negative benzylpenicillin G skin test. JClin Pharm Ther 2009, 34:249-254.
7. Hjortlund J., Mortz C.G., Skov P.S., et al. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 2013, 68:1057-1064.
8. Macy E., Goldberg B., Poon K.Y. Use of commercial anti-penicillin IgE fluorometric enzyme immunoassays to diagnose penicillin allergy. Ann Allergy Asthma Immunol 2010, 105:136-141.
9. Johansson S.G., Adedoyin J., van Hage M., et al. False-positive penicillin immunoassay: an unnoticed common problem. JAllergy Clin Immunol 2013, 132:235-237.
10. Fisher M.M., Baldo B.A. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 2000, 28:167-170.
11. Ebo D.G., Venemalm L., Bridts C.H., et al. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. Anesthesiology 2007, 107:253-259.
12. Laroche D., Chollet-Martin S., Leturgie P., et al. Evaluation of a new routine diagnostic test for immunoglobulin E sensitization to neuromuscular blocking agents. Anesthesiology 2011, 114:91-97.
13. Florvaag E., Johansson S.G., Oman H., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005, 49:437-444.
14. Fisher M.M., Baldo B.A. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993, 12:97-104.
15. Pham N.H., Baldo B.A., Puy R.M. Studies on the mechanism of multiple drug allergies. Structural basis of drug recognition. JImmunoassay Immunochem 2001, 22:47-73.
16. Leysen J., De Witte L., Sabato V., et al. IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: lessons from flow cytometry. Cytometry B Clin Cytom 2013, 84:65-70.
17. Dong S.W., Mertes P.M., Petitpain N., et al. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol 2012, 78:868-878.
18. Ebo D.G., Stevens W.J., Bridts C.H., et al. Latex-specific IgE, skin testing, and lymphocyte transformation to latex in latex allergy. JAllergy Clin Immunol 1997, 100:618-623.
19. Plebani M., Borghesan F., Basso D., et al. Receiver-operating characteristic (ROC) curves: a fundamental tool for improving the clinical usefulness of invitro IgE tests. Allergy 1996, 51:407-411.
20. Greiner M., Pfeiffer D., Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000, 45:23-41.
21. Pham N.H., Baldo B.A. Beta-lactam drug allergens: fine structural recognition patterns of cephalosporin-reactive IgE antibodies. JMol Recognit 1996, 9:287-296.
22. Demoly P., Lebel B., Arnoux B. Allergen-induced mediator release tests. Allergy 2003, 58:553-558.
23. Knol E.F., Mul F.P., Jansen H., et al. Monitoring human basophil activation via CD63 monoclonal antibody 435. JAllergy Clin Immunol 1991, 88:328-338.
24. Ebo D.G., Hagendorens M.M., Bridts C.H., et al. Invitro allergy diagnosis: should we follow the flow?. Clin Exp Allergy 2004, 34:332-339.
25. Ebo D.G., Dombrecht E.J., Bridts C.H., et al. Combined analysis of intracellular signalling and immunophenotype of human peripheral blood basophils by flow cytometry: a proof of concept. Clin Exp Allergy 2007, 37:1668-1675.
26. Aerts N.E., Dombrecht E.J., Bridts C.H., et al. Simultaneous flow cytometric detection of basophil activation marker CD63 and intracellular phosphorylated p38 mitogen-activated protein kinase in birch pollen allergy. Cytometry B Clin Cytom 2009, 76:8-17.
27. Ebo D.G., Bridts C.H., Mertens C.H., et al. Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils. JImmunol Methods 2012, 375:30-38.
28. Hausmann O.V., Gentinetta T., Bridts C.H., et al. The basophil activation test in immediate-type drug allergy. Immunol Allergy Clin North Am 2009, 29:555-566.
29. Leysen J., Sabato V., Verweij M.M., et al. The basophil activation test in the diagnosis of immediate drug hypersensitivity. Expert Rev Clin Immunol 2011, 7:349-355.
30. Gamboa P.M., Garcia-Aviles M.C., Urrutia I., et al. Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests. JInvestig Allergol Clin Immunol 2004, 14:278-283.
31. Ebo D.G., Bridts C.H., Hagendorens M.M., et al. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy 2006, 61:935-939.
32. Pinnobphun P., Buranapraditkun S., Kampitak T., et al. The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media. Ann Allergy Asthma Immunol 2011, 106:387-393.
33. Jones S.C., Budnitz D.S., Sorbello A., et al. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. Pharmacoepidemiol Drug Saf 2013, 22:1099-1106.
34. Baldo B.A., Pham N.H. Drug allergy. clinical aspects, diagnosis, mechanisms, structure-activity relationships 2013, Springer, New York.
35. Aranda A., Mayorga C., Ariza A., et al. Invitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011, 66:247-254.
36. Seitz C.S., Brocker E.B., Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy 2009, 39:1738-1745.
37. Lobera T., Audicana M.T., Alarcon E., et al. Allergy to quinolones: low cross-reactivity to levofloxacin. JInvestig Allergol Clin Immunol 2010, 20:607-611.
38. Ben S.B., Berard F., Bienvenu J., et al. Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones. Allergy 2010, 65:535-536.
39. Rouzaire P., Nosbaum A., Denis L., et al. Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decision-making. Int Arch Allergy Immunol 2012, 157:299-302.
40. Thong B.Y., Mirakian R., Castells M., et al. AWorld Allergy Organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. World Allergy Organ J 2011, 4:257-270.
41. Gamboa P.M., Sanz M.L., Caballero M.R., et al. Use of CD63 expression as a marker of invitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 2003, 58:312-317.
42. Gomez E., Blanca-Lopez N., Torres M.J., et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009, 39:1217-1224.
43. Couto M., Gaspar A., Piedade S., et al. IgE-mediated metamizol allergy and the usefulness of the cellular allergen stimulation test. Eur Ann Allergy Clin Immunol 2012, 44:113-116.
44. Malbran A., Yeyati E., Rey G.L., et al. Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin Exp Immunol 2007, 147:99-105.
45. Bavbek S., Ikinciogullari A., Dursun A.B., et al. Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance. Int Arch Allergy Immunol 2009, 150:261-270.
46. Celik G.E., Schroeder J.T., Hamilton R.G., et al. Effect of invitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy 2009, 39:1522-1531.
47. Majlesi Y., Samorapoompichit P., Hauswirth A.W., et al. Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3. JLeukoc Biol 2003, 73:107-117.
48. Fernandez T.D., Torres M.J., Blanca-Lopez N., et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 2009, 64:242-248.
49. Kvedariene V., Kamey S., Ryckwaert Y., et al. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils. Allergy 2006, 61:311-315.